SPY423.86-1.40 -0.33%
DIA342.53-1.77 -0.51%
IXIC14,078.90-95.24 -0.67%

BRIEF-Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA

05/10/2021 09:10
BRIEF-Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA

- Amgen Inc AMGN.O:

  • AMGEN ANNOUNCES TEZEPELUMAB BIOLOGICS LICENSE APPLICATION SUBMITTED TO U.S. FDA

  • AMGEN INC - CO'S PARTNER ASTRAZENECA SUBMITTED A BIOLOGICS LICENSE APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR TEZEPELUMAB

Source text for Eikon: ID:nPn1ng5Q3a

Further company coverage: AMGN.O


(([email protected];))